27
Participants
Start Date
July 31, 2007
Primary Completion Date
April 30, 2011
Study Completion Date
April 30, 2011
Imetelstat Sodium (GRN163L)
"The starting dose of GRN163L for this study will be 3.2 mg/kg. Subsequent dose levels will be 4.8, 6, 7.5, 9, 11, and 13.5 mg/kg. The maximum dose to be administered will not exceed 13.5 mg/kg.~Paclitaxel and carboplatin will be administered on Day 2 of each 21-day cycle."
University of Maryland Greenebaum Cancer Center, Baltimore
University of Wisconsin, Paul P. Carbone Comprehensive Cancer Center, Madison
The University of Texas Southwestern Medical Center, Dallas
UT MD Anderson Cancer Center, Houston
Lead Sponsor
Geron Corporation
INDUSTRY